125 results
Patient safety
Yes Remove Yes filter
-
List item
News: CHMP endorses review finding no link between viral vector in Zynteglo and blood cancer
CAT, CHMP, Last updated: 23/07/2021 -
List item
News: Benefits of ifosfamide solutions continue to outweigh risks EMA’s safety committee (PRAC) has concluded that the benefits of ifosfamide solutions for infusion
PRAC, Last updated: 12/03/2021 -
List item
News: Nitrosamines: EMA aligns recommendations for sartans with those for other medicines
CHMP, Last updated: 13/11/2020 -
List item
News: Ulipristal acetate for uterine fibroids: EMA recommends restricting use
CHMP, Last updated: 13/11/2020 -
List item
News: PRAC recommends revoking marketing authorisation of ulipristal acetate for uterine fibroids
PRAC, Last updated: 04/09/2020 -
List item
News: Authorised uses of cancer medicine Yondelis unchanged following review of new data
CHMP, Last updated: 24/07/2020 -
List item
Press release: EMA finalises opinion on presence of nitrosamines in medicines
Last updated: 09/07/2020 -
List item
Press release: European regulators make recommendations drawing on lessons learnt from presence of nitrosamines in sartan medicines
Last updated: 23/06/2020 -
List item
Press release: COVID-19: reminder of the risks of chloroquine and hydroxychloroquine
Last updated: 29/05/2020 -
List item
Press release: Leuprorelin depot medicines: PRAC recommends new measures to avoid handling errors
PRAC, Last updated: 15/05/2020 -
List item
Press release: Risks of Picato for actinic keratosis outweigh benefits
CHMP, Last updated: 30/04/2020 -
List item
Press release: EMA recommendations on DPD testing prior to treatment with fluorouracil, capecitabine, tegafur and flucytosine
CHMP, Last updated: 30/04/2020 -
List item
Press release: Suspension of ranitidine medicines in the EU
CHMP, Last updated: 30/04/2020 -
List item
Press release: EMA review of Picato concludes medicine’s risks outweigh its benefits
PRAC, Last updated: 17/04/2020 -
List item
Press release: Restrictions in use of cyproterone due to meningioma risk
CMDh, Last updated: 27/03/2020 -
List item
Press release: Recommendations to restrict use of fosfomycin antibiotics
CHMP, Last updated: 27/03/2020 -
List item
Press release: No change is needed in use of direct oral anticoagulants following EMA-funded study
CHMP, Last updated: 27/03/2020 -
List item
Press release: Benefits of medicines containing combination of methocarbamol and paracetamol continue to outweigh risks
CHMP, Last updated: 27/03/2020 -
List item
Press release: Suspension of ulipristal acetate for uterine fibroids during ongoing EMA review of liver injury risk
PRAC, Last updated: 13/03/2020 -
List item
Press release: Update on nitrosamines in EU medicines
Last updated: 03/03/2020 -
List item
Press release: Restrictions in use of cyproterone due to meningioma risk
PRAC, Last updated: 14/02/2020 -
List item
Press release: EMA suspends Picato as a precaution while review of skin cancer risk continues
PRAC, Last updated: 17/01/2020 -
List item
Press release: PRAC confirms four-week limit for use of high-strength estradiol creams
PRAC, Last updated: 17/01/2020 -
List item
Press release: EMA update on metformin diabetes medicines
Last updated: 06/12/2019 -
List item
Press release: EMA confirms Xeljanz to be used with caution in patients at high risk of blood clots
CHMP, Last updated: 15/11/2019